Neuroprotection for ischemic stroke: Past, present and future
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aarts, 2003, Novel treatment of excitotoxicity: targeted disruption of intracellular signalling from glutamate receptors, Biochem. Pharmacol., 66, 877, 10.1016/S0006-2952(03)00297-1
Adibhatla, 2003, Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia, Antioxid. Redox. Signal, 5, 647, 10.1089/152308603770310329
Adibhatla, 2006, CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke, J. Biol. Chem., 281, 6718, 10.1074/jbc.M512112200
Aichner, 1998, Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST), Stroke, 29, 743, 10.1161/01.STR.29.4.743
Albers, 1995, Safety, tolerability, and pharmacokinetics of the N-methyl-d-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group, Stroke, 26, 254, 10.1161/01.STR.26.2.254
Albers, 2001, Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial, J. Am. Med. Assoc., 286, 2673, 10.1001/jama.286.21.2673
Allen, 1983, Cerebral arterial spasm – a controlled trial of nimodipine in patients with subarachnoid hemorrhage, N. Engl. J. Med., 308, 619, 10.1056/NEJM198303173081103
Alonso de Lecinana, 2006, Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke, J. Neurol. Sci., 247, 121, 10.1016/j.jns.2006.03.022
Amemiya, 2005, Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats, Eur. J. Pharmacol., 516, 125, 10.1016/j.ejphar.2005.04.036
American Nimodipine Study Group, 1992, Clinical trial of nimodipine in acute ischemic stroke. The American Nimodipine Study Group, Stroke, 23, 3, 10.1161/01.STR.23.1.3
Andersen, 1999, Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model, Stroke, 30, 1464, 10.1161/01.STR.30.7.1464
Argentino, 1989, GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study – Hemodilution+Drug, Stroke, 20, 1143, 10.1161/01.STR.20.9.1143
Aronowski, 1996, Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome, Neurol. Res., 18, 570, 10.1080/01616412.1996.11740473
Aronowski, 1996, Treatment of experimental focal ischemia in rats with lubeluzole, Neuropharmacology, 35, 689, 10.1016/0028-3908(96)84640-5
Arundine, 2004, Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury, Cell. Mol. Life Sci., 61, 657, 10.1007/s00018-003-3319-x
Ashton, 1997, Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs, Brain Res., 745, 210, 10.1016/S0006-8993(96)01094-3
Asplund, 2002, Haemodilution for acute ischaemic stroke, Cochrane Database Syst. Rev, CD000103
Back, 1998, Pathophysiology of the ischemic penumbra – revision of a concept, Cell. Mol. Neurobiol., 18, 621, 10.1023/A:1020265701407
Barone, 1999, Inflammatory mediators and stroke: new opportunities for novel therapeutics, J. Cereb. Blood Flow Metab., 19, 819, 10.1097/00004647-199908000-00001
Barone, 1997, Brain cooling during transient focal ischemia provides complete neuroprotection, Neurosci. Biobehav. Rev., 21, 31, 10.1016/0149-7634(95)00080-1
Bazan, 2005, Lipid signaling in neural plasticity, brain repair, and neuroprotection, Mol. Neurobiol., 32, 89, 10.1385/MN:32:1:089
Becker, 2002, Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants, J. Am. Chem. Soc., 124, 4678, 10.1021/ja011507s
Becker, 1998, Redox behaviour of azulenyl nitrones: fully reversible one electron oxidation by cyclic voltammetry at potentials within the range of biological antioxidants, JCS Perkin Trans., 2, 1289, 10.1039/a708702k
Belayev, 1997, Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats, J. Neurosurg., 87, 595, 10.3171/jns.1997.87.4.0595
Belayev, 1997, Transient middle cerebral artery occlusion by intraluminal suture: I. Three-dimensional autoradiographic image-analysis of local cerebral glucose metabolism-blood flow interrelationships during ischemia and early recirculation, J. Cereb. Blood Flow Metab., 17, 1266, 10.1097/00004647-199712000-00002
Belayev, 1998, Diffusion-weighted magnetic resonance imaging confirms marked neuroprotective efficacy of albumin therapy in focal cerebral ischemia, Stroke, 29, 2587, 10.1161/01.STR.29.12.2587
Belayev, 1999, Posttreatment with high-dose albumin reduces histopathological damage and improves neurological deficit following fluid percussion brain injury in rats, J. Neurotrauma, 16, 445, 10.1089/neu.1999.16.445
Belayev, 1999, Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats, Brain Res., 845, 107, 10.1016/S0006-8993(99)01952-6
Belayev, 2001, Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window, Stroke, 32, 553, 10.1161/01.STR.32.2.553
Belayev, 2002, Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses, Stroke, 33, 1077, 10.1161/hs0402.105555
Benveniste, 1991, The excitotoxin hypothesis in relation to cerebral ischemia, Cerebrovasc. Brain Metab. Rev., 3, 213
Bernard, 2002, Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia, N. Engl. J. Med., 346, 557, 10.1056/NEJMoa003289
Billups, 1998, Physiological and pathological operation of glutamate transporters, Prog. Brain Res., 116, 45, 10.1016/S0079-6123(08)60429-X
Bogousslavsky, 2002, Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial, Cerebrovasc. Dis., 14, 239, 10.1159/000065683
Bonvento, 1991, Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia, Brain Res. Brain Res. Rev., 16, 257, 10.1016/0165-0173(91)90009-W
Bonventre, 1997, Roles of phospholipases A2 in brain cell and tissue injury associated with ischemia and excitotoxicity, J. Lipid Mediat. Cell Signal, 16, 199
Bordi, 1997, The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat, Exp. Neurol., 145, 425, 10.1006/exnr.1997.6442
Bordi, 1999, The neuroprotective glycine receptor antagonist GV150526 does not produce neuronal vacuolization or cognitive deficits in rats, Eur. J. Pharmacol., 378, 153, 10.1016/S0014-2999(99)00462-8
Bozzi, 2006, Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?, Trends Neurosci, 29, 167, 10.1016/j.tins.2006.01.002
Bruno, 2001, Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs, J. Cereb. Blood Flow Metab., 21, 1013, 10.1097/00004647-200109000-00001
Buettner, 1993, The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate, Arch. Biochem. Biophys., 300, 535, 10.1006/abbi.1993.1074
Busto, 1998, The influence of altered brain temperature in cerebral ischemia, 287
Candelise, 2001, Gangliosides for acute ischaemic stroke, Cochrane Database Syst. Rev, CD000094
Castillo, 1998, Timing for fever-related brain damage in acute ischemic stroke, Stroke, 29, 2455, 10.1161/01.STR.29.12.2455
Chan, 2001, Reactive oxygen radicals in signaling and damage in the ischemic brain, J. Cereb. Blood Flow Metab., 21, 2, 10.1097/00004647-200101000-00002
Chan, 1995, Transgenic mice and knockout mutants in the study of oxidative stress in brain injury, J. Neurotrauma, 12, 815, 10.1089/neu.1995.12.815
Charriaut-Marlangue, 1996, Apoptotic features of selective neuronal death in ischemia, epilepsy and gp 120 toxicity, Trends Neurosci., 19, 109, 10.1016/S0166-2236(96)80039-7
Chaulk, 2003, Long-term effects of clomethiazole in a model of global ischemia, Exp. Neurol., 182, 476, 10.1016/S0014-4886(03)00121-3
Chen, 2003, Astrocytes and brain injury, J. Cereb. Blood Flow Metab., 23, 137, 10.1097/00004647-200302000-00001
Cheng, 2004, Neuroprotection for ischemic stroke: two decades of success and failure, NeuroRx, 1, 36, 10.1602/neurorx.1.1.36
Chesler, 2005, Failure and function of intracellular pH regulation in acute hypoxic-ischemic injury of astrocytes, Glia, 50, 398, 10.1002/glia.20141
Choi, 1995, Calcium: still center-stage in hypoxic-ischemic neuronal death, Trends Neurosci., 18, 58, 10.1016/0166-2236(95)93870-4
Choi, 1990, The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death, Annu. Rev. Neurosci., 13, 171, 10.1146/annurev.ne.13.030190.001131
Clark, 1997, A randomized dose–response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group, Neurology, 49, 671, 10.1212/WNL.49.3.671
Clark, 1999, Cervene in acute ischemic stroke: results of a double-blind, placebo-controlled, dose-comparison study, J. Stroke Cerebrovasc. Dis., 8, 224, 10.1016/S1052-3057(99)80071-8
Clark, 1999, A randomized efficacy trial of citicoline in patients with acute ischemic stroke, Stroke, 30, 2592, 10.1161/01.STR.30.12.2592
Clark, 2000, Cervene (Nalmefene) in acute ischemic stroke: final results of a phase III efficacy study. The Cervene Stroke Study Investigators, Stroke, 31, 1234, 10.1161/01.STR.31.6.1234
Clark, 2001, A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients, Neurology, 57, 1595, 10.1212/WNL.57.9.1595
Colbourne, 1997, Postischemic hypothermia. A critical appraisal with implications for clinical treatment, Mol. Neurobiol., 14, 171, 10.1007/BF02740655
Colbourne, 1999, Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats, J. Cereb. Blood Flow Metab., 19, 742, 10.1097/00004647-199907000-00003
Corbett, 2000, Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia, Brain Pathol., 10, 145, 10.1111/j.1750-3639.2000.tb00251.x
Culmsee, 1998, Lubeluzole protects hippocampal neurons from excitotoxicity in vitro and reduces brain damage caused by ischemia, Eur. J. Pharmacol., 342, 193, 10.1016/S0014-2999(97)01499-4
Curry, 1998, Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites, Nat. Struct. Biol., 5, 827, 10.1038/1869
Dalkara, 1998, Mechanisms of NO neurotoxicity, Prog. Brain Res., 118, 231, 10.1016/S0079-6123(08)63211-2
Davalos, 2002, Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials, Stroke, 33, 2850, 10.1161/01.STR.0000038691.03334.71
Davis, 1997, Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committee, Lancet, 349, 32, 10.1016/S0140-6736(05)62166-6
Davis, 2000, Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist, Stroke, 31, 347, 10.1161/01.STR.31.2.347
Dawson, 2001, A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke, Brain Res., 892, 344, 10.1016/S0006-8993(00)03269-8
De Deyn, 1997, Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group, Stroke, 28, 2347, 10.1161/01.STR.28.12.2347
De Georgia, 2004, Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling, Neurology, 63, 312, 10.1212/01.WNL.0000129840.66938.75
De Ryck, 1996, Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats, J. Pharmacol. Exp. Ther., 279, 748
De Ryck, 2000, Diffusion-weighted MRI of infarct growth in a rat photochemical stroke model: effect of lubeluzole, Neuropharmacology., 39, 691, 10.1016/S0028-3908(99)00176-8
DeGracia, 2004, Cerebral ischemia and the unfolded protein response, J. Neurochem., 91, 1, 10.1111/j.1471-4159.2004.02703.x
DeGracia, 2002, Molecular pathways of protein synthesis inhibition during brain reperfusion: implications for neuronal survival or death, J. Cereb. Blood Flow Metab., 22, 127, 10.1097/00004647-200202000-00001
Dehouck, 2002, In vitro blood–brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions, Brain Res., 955, 229, 10.1016/S0006-8993(02)03469-8
del Zoppo, 2003, Cerebral microvessel responses to focal ischemia, J. Cereb. Blood Flow Metab., 23, 879, 10.1097/01.WCB.0000078322.96027.78
Dewar, 2003, Oligodendrocytes and ischemic brain injury, J. Cereb. Blood Flow Metab., 23, 263, 10.1097/00004647-200303000-00001
Diener, 1998, Multinational randomised controlled trial of lubeluzole in acute ischaemic Stroke European and Australian Lubeluzole Ischaemic Stroke Study Group, Cerebrovasc. Dis., 8, 172, 10.1159/000015847
Diener, 1996, Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group, Stroke, 27, 76, 10.1161/01.STR.27.1.76
Diener, 2000, Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo, Stroke, 31, 2543, 10.1161/01.STR.31.11.2543
Diringer, 2004, Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system, Crit. Care Med., 32, 559, 10.1097/01.CCM.0000108868.97433.3F
Dirnagl, 2006, Bench to bedside: the quest for quality in experimental stroke research, J. Cereb. Blood Flow Metab., 26, 1465, 10.1038/sj.jcbfm.9600298
Dirnagl, 2003, Ischemic tolerance and endogenous neuroprotection, Trends Neurosci., 26, 248, 10.1016/S0166-2236(03)00071-7
Dixon, 2002, Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction, J. Am. Coll. Cardiol., 40, 1928, 10.1016/S0735-1097(02)02567-6
Dorman, 1999, Reports of randomized trials in acute stroke, 1955 to 1995. What proportions were commercially sponsored?, Stroke, 30, 1995, 10.1161/01.STR.30.10.1995
Doufas, 2004, Physiology and clinical relevance of induced hypothermia, Neurocrit. Care, 1, 489, 10.1385/NCC:1:4:489
Duley, 2003, Magnesium sulphate and other anticonvulsants for women with pre-eclampsia, Cochrane Database Syst. Rev, CD000025
Dyker, 1999, Safety and tolerability of GV150526 (a glycine site antagonist at the N-methyl-d-aspartate receptor) in patients with acute stroke, Stroke, 30, 986, 10.1161/01.STR.30.5.986
EAST Trial, 2001, Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial, Neurology, 57, 1428, 10.1212/WNL.57.8.1428
Edaravone Acute Infarction Study, 2003, Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters, Cerebrovasc. Dis., 15, 222, 10.1159/000069318
Elting, 2002, AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels, Stroke, 33, 2813, 10.1161/01.STR.0000043823.37955.FB
Endres, 2004, Targeting eNOS for stroke protection, Trends Neurosci., 27, 283, 10.1016/j.tins.2004.03.009
Erecinska, 1996, Calcium handling by hippocampal neurons under physiologic and pathologic conditions, Adv. Neurol., 71, 119
Erecinska, 2003, Effects of hypothermia on energy metabolism in Mammalian central nervous system, J. Cereb. Blood Flow Metab., 23, 513, 10.1097/01.WCB.0000066287.21705.21
Faraci, 1998, Regulation of the cerebral circulation: role of endothelium and potassium channels, Physiol. Rev., 78, 53, 10.1152/physrev.1998.78.1.53
FAST-MAG Trial website
Ferrer, 2003, Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra, J. Neuropathol. Exp. Neurol., 62, 329, 10.1093/jnen/62.4.329
Feuerstein, 2008, Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke, J. Cereb. Blood Flow Metab., 28, 217, 10.1038/sj.jcbfm.9600516
Fiskum, 2000, Mitochondrial participation in ischemic and traumatic neural cell death, J. Neurotrauma, 17, 843, 10.1089/neu.2000.17.843
Franke, 1996, Flunarizine in stroke treatment (FIST): a double-blind, placebo-controlled trial in Scandinavia and the Netherlands, Acta Neurol. Scand, 93, 56, 10.1111/j.1600-0404.1996.tb00171.x
Friberg, 2002, Mitochondrial permeability transition in acute neurodegeneration, Biochimie, 84, 241, 10.1016/S0300-9084(02)01381-0
Fukunaga, 2003, Akt is a molecular target for signal transduction therapy in brain ischemic insult, J. Pharmacol. Sci., 92, 317, 10.1254/jphs.92.317
Furuya, 2001, Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study, Stroke, 32, 2665, 10.1161/hs3211.098535
Gandolfo, 2002, Lubeluzole for acute ischaemic stroke, Cochrane Database Syst. Rev, CD001924
Garber, 2007, Stroke treatment – light at the end of the tunnel?, Nat. Biotechnol., 25, 838, 10.1038/nbt0807-838
Gasche, 2006, Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain, Front Biosci., 11, 1289, 10.2741/1883
Gelmers, 1988, A controlled trial of nimodipine in acute ischemic stroke, N. Engl. J. Med., 318, 203, 10.1056/NEJM198801283180402
Gibson, 2006, Estrogens and experimental ischemic stroke: a systematic review, J. Cereb. Blood Flow Metab., 26, 1103, 10.1038/sj.jcbfm.9600270
Gidday, 2006, Cerebral preconditioning and ischaemic tolerance, Nat. Rev. Neurosci., 7, 437, 10.1038/nrn1927
Gill, 1994, The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia, Cerebrovasc. Brain Metab. Rev., 6, 225
Ginsberg, 1990, Local metabolic responses to cerebral ischemia, Cerebrovasc. Brain Metab. Rev., 2, 58
Ginsberg, 1995, Neuroprotection in brain ischemia – an update – Parts I and II, Neuroscientist, 1, 95, 10.1177/107385849500100206
Ginsberg, 2007, Life after Cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era, Stroke, 38, 1967, 10.1161/STROKEAHA.106.479170
Ginsberg, 2005, Biological and molecular mechanisms of hypothermic neuroprotection, 85
Ginsberg, 1998, Combating hyperthermia in acute stroke: a significant clinical concern, Stroke, 29, 529, 10.1161/01.STR.29.2.529
Ginsberg, 1998, Small-animal models of global and focal cerebral ischemia, 14
Ginsberg, 1992, Therapeutic modulation of brain temperature: relevance to ischemic brain injury, Cerebrovasc. Brain Metab. Rev., 4, 189
Ginsberg, 2003, Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia, Ann. Neurol., 54, 330, 10.1002/ana.10659
Ginsberg, 2004, Albumin-based neurotherapeutics for acute ischemic stroke: from bench to bedside, 421
Ginsberg, 2006, The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke. I. Physiological responses and safety results, Stroke, 37, 2100, 10.1161/01.STR.0000231388.72646.05
Ginsberg, 2006, The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report, Biochem. Soc. Trans., 34, 1323, 10.1042/BST0341323
Gluckman, 2005, Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial, Lancet, 365, 663, 10.1016/S0140-6736(05)17946-X
Goldstein, 1999, Clinical stroke trials: guarding against bias, Stroke, 30, 1165, 10.1161/01.STR.30.6.1165
Gorelick, 2000, Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?, Lancet, 355, 1925, 10.1016/S0140-6736(00)02318-7
Goslinga, 1992, Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke, Stroke, 23, 181, 10.1161/01.STR.23.2.181
Graham, 1992, Hypoxia and vascular disorders, 153
Graham, 2001, Programmed cell death in cerebral ischemia, J. Cereb. Blood Flow Metab., 21, 99, 10.1097/00004647-200102000-00001
Green, 2003, Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059, Pharmacol. Ther., 100, 195, 10.1016/j.pharmthera.2003.07.003
Gribkoff, 2001, Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels, Nat. Med., 7, 471, 10.1038/86546
Grotta, 1997, Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group, Stroke, 28, 2338, 10.1161/01.STR.28.12.2338
Grotta, 1995, Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial, Stroke, 26, 602, 10.1161/01.STR.26.4.602
Guluma, 2006, A trial of therapeutic hypothermia via endovascular approach in awake patients with acute ischemic stroke: methodology, Acad. Emerg. Med., 13, 820, 10.1111/j.1553-2712.2006.tb01731.x
Gunn, 2005, Therapeutic hypothermia: from lab to NICU, J. Perinat. Med., 33, 340, 10.1515/JPM.2005.061
Haass, 1986, Dextran 40 or HES 200/0.5? Hemorheology of the long-term treatment of ischemic cerebral attacks, Dtsch. Med. Wochenschr, 111, 1681
Haley, 2005, Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies, Stroke, 36, 1006, 10.1161/01.STR.0000163053.77982.8d
Halliwell, 1988, Albumin – an important extracellular antioxidant?, Biochem. Pharmacol., 37, 569, 10.1016/0006-2952(88)90126-8
Hansen, 1995, The importance of glutamate receptors in brain ischemia, Adv. Exp. Med. Biol., 363, 123, 10.1007/978-1-4615-1857-0_14
Hartl, 1996, Experimental antileukocyte interventions in cerebral ischemia, J. Cereb. Blood Flow Metab., 16, 1108, 10.1097/00004647-199611000-00004
Haseldonckx, 1997, Protection with lubeluzole against delayed ischemic brain damage in rats. A quantitative histopathologic study, Stroke, 28, 428, 10.1161/01.STR.28.2.428
He, 1993, Albumin modulation of capillary permeability: role of endothelial cell [Ca2+]i, Am. J. Physiol., 265, H74
Heiss, 2000, Ischemic penumbra: evidence from functional imaging in man, J. Cereb. Blood Flow Metab., 20, 1276, 10.1097/00004647-200009000-00002
Heiss, 1983, Functional recovery of cortical neurons as related to degree and duration of ischemia, Ann. Neurol., 14, 294, 10.1002/ana.410140307
Hemmen, 2007, Induced hypothermia for acute stroke, Stroke, 38, 794, 10.1161/01.STR.0000247920.15708.fa
Hertz, 1981, Features of astrocytic function apparently involved in the response of central nervous tissue to ischemia-hypoxia, J. Cereb. Blood Flow Metab., 1, 143, 10.1038/jcbfm.1981.17
Horn, 2000, Calcium antagonists for acute ischemic stroke, Cochrane Database Syst. Rev, CD001928
Horn, 2001, Very Early Nimodipine Use in Stroke (VENUS): a randomized, double-blind, placebo-controlled trial, Stroke, 32, 461, 10.1161/01.STR.32.2.461
Horn, 2001, Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review, Stroke, 32, 2433, 10.1161/hs1001.096009
Hossmann, 1994, Glutamate-mediated injury in focal cerebral ischemia: the excitotoxin hypothesis revised, Brain Pathol., 4, 23, 10.1111/j.1750-3639.1994.tb00808.x
Hossmann, 1994, Viability thresholds and the penumbra of focal ischemia, Ann. Neurol., 36, 557, 10.1002/ana.410360404
Hou, 2002, Molecular mechanisms of cerebral ischemia-induced neuronal death, Int. Rev. Cytol., 221, 93, 10.1016/S0074-7696(02)21011-6
Hoyte, 2004, The rise and fall of NMDA antagonists for ischemic stroke, Curr. Mol. Med., 4, 131, 10.2174/1566524043479248
Hsu, 1988, Pentoxifylline in acute nonhemorrhagic stroke. A randomized, placebo-controlled double-blind trial, Stroke, 19, 716, 10.1161/01.STR.19.6.716
Hudetz, 1997, Blood flow in the cerebral capillary network: a review emphasizing observations with intravital microscopy, Microcirculation, 4, 233, 10.3109/10739689709146787
Huh, 1998, The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats, Brain Res., 804, 105, 10.1016/S0006-8993(98)00674-X
Huh, 2000, Comparative neuroprotective efficacy of prolonged moderate intraischemic and postischemic hypothermia in focal cerebral ischemia, J. Neurosurg., 92, 91, 10.3171/jns.2000.92.1.0091
Hurn, 2000, Estrogen as a neuroprotectant in stroke, J. Cereb. Blood Flow Metab., 20, 631, 10.1097/00004647-200004000-00001
Hurtado, 2005, Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport, Neurobiol. Dis., 18, 336, 10.1016/j.nbd.2004.10.006
Hurtado, 2007, A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke, Neurobiol. Dis., 26, 105, 10.1016/j.nbd.2006.12.005
Hypothermia After Cardiac Arrest Study Group, 2002, Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest, N. Engl. J. Med., 346, 549, 10.1056/NEJMoa012689
Iadecola, 1997, Bright and dark sides of nitric oxide in ischemic brain injury, Trends Neurosci., 20, 132, 10.1016/S0166-2236(96)10074-6
Iadecola, 1994, Nitric oxide synthase inhibition and cerebrovascular regulation, J. Cereb. Blood Flow Metab., 14, 175, 10.1038/jcbfm.1994.25
Imai, 2001, Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia, Stroke, 32, 2149, 10.1161/hs0901.095725
Internet Stroke Center
Irving, 2002, Role of mitogen- and stress-activated kinases in ischemic injury, J. Cereb. Blood Flow Metab., 22, 631, 10.1097/00004647-200206000-00001
Italian Acute Stroke Study Group, 1988, Haemodilution in acute stroke: results of the Italian haemodilution trial. Italian Acute Stroke Study Group, Lancet, 1, 318
Izumi, 1991, Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats, J. Cereb. Blood Flow Metab., 11, 1025, 10.1038/jcbfm.1991.170
Jian, 2005, Matrix metalloproteinases and free radicals in cerebral ischemia, Free Radic. Biol. Med., 39, 71, 10.1016/j.freeradbiomed.2005.03.033
Johansson, 2007, Regeneration and plasticity in the brain and spinal cord, J. Cereb. Blood Flow Metab., 27, 1417, 10.1038/sj.jcbfm.9600486
Johnson, 1995, Neuronal apoptosis: current understanding of molecular mechanisms and potential role in ischemic brain injury, J. Neurotrauma, 12, 843, 10.1089/neu.1995.12.843
Kammersgaard, 2000, Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study: the Copenhagen Stroke Study, Stroke, 31, 2251, 10.1161/01.STR.31.9.2251
Kaste, 1994, A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke, Stroke, 25, 1348, 10.1161/01.STR.25.7.1348
Kazda, 1982, Nimodipine: a new calcium antagonistic drug with a preferential cerebrovascular action, Acta Neurochir. (Wien), 63, 259, 10.1007/BF01728880
Keaney, 1993, NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties, J. Clin. Invest, 91, 1582, 10.1172/JCI116364
Kilpatrick, 2000, Hyperthermia in the neurosurgical intensive care unit, Neurosurgery, 47, 850, 10.1097/00006123-200010000-00011
Kimberger, 2007, Meperidine and skin surface warming additively reduce the shivering threshold: a volunteer study, Crit. Care, 11, R29, 10.1186/cc5709
Kirino, 2002, Ischemic tolerance, J. Cereb. Blood Flow Metab., 22, 1283, 10.1097/00004647-200211000-00001
Kitano, 2007, Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain, J. Cereb. Blood Flow Metab., 27, 1108, 10.1038/sj.jcbfm.9600410
Koehler, 1998, Large-animal models of focal and global cerebral ischemia, 36
Kong, 2002, Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: a randomized controlled trial, Anesthesiology, 97, 585, 10.1097/00000542-200209000-00011
Koziol, 2006, On the analysis and interpretation of outcome measures in stroke clinical trials: lessons from the SAINT I study of NXY-059 for acute ischemic stroke, Stroke, 37, 2644, 10.1161/01.STR.0000241106.81293.2b
Krams, 2003, Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose–response study of UK-279,276 in acute ischemic stroke, Stroke, 34, 2543, 10.1161/01.STR.0000092527.33910.89
Krieger, 2004, Radiant Medical Reprieve Endovascular Temperature Therapy System, Neurocrit. Care, 1, 205, 10.1385/NCC:1:2:205
Kuroda, 1999, Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat, J. Cereb. Blood Flow Metab., 19, 778, 10.1097/00004647-199907000-00008
Lapchak, 2002, Effects of the spin trap agent disodium-[tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: combination studies with tissue plasminogen activator, Stroke, 33, 1665, 10.1161/01.STR.0000017145.22806.AA
Lapchak, 2002, Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator, Stroke, 33, 1411, 10.1161/01.STR.0000015346.00054.8B
Lascola, 1997, Astroglial acid-base dynamics in hyperglycemic and normoglycemic global ischemia, Neurosci. Biobehav. Rev., 21, 143, 10.1016/S0149-7634(96)00004-8
Lees, 2000, Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders, Drugs, 59, 33, 10.2165/00003495-200059010-00004
Lees, 2000, Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators, Lancet, 355, 1949, 10.1016/S0140-6736(00)02326-6
Lenzi, 1994, Early treatment of stroke with monosialoganglioside GM-1. Efficacy and safety results of the Early Stroke Trial, Stroke, 25, 1552, 10.1161/01.STR.25.8.1552
Lesage, 1996, Lubeluzole, a novel long-term neuroprotectant, inhibits the glutamate-activated nitric oxide synthase pathway, J. Pharmacol. Exp. Ther., 279, 759
Li, 1993, Treatment with an AMPA antagonist 12hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury, J. Cereb. Blood Flow Metab., 13, 933, 10.1038/jcbfm.1993.116
Liang, 2004, What have genetically engineered mice taught us about ischemic injury?, Curr. Mol. Med., 4, 207, 10.2174/1566524043479194
Lichtenwalner, 2006, Adult neurogenesis and the ischemic forebrain, J. Cereb. Blood Flow Metab., 26, 1, 10.1038/sj.jcbfm.9600170
Lipton, 2007, Pathologically activated therapeutics for neuroprotection, Nat. Rev. Neurosci., 8, 803, 10.1038/nrn2229
Liu, 2001, Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies, Eur. J. Pharmacol., 428, 193, 10.1016/S0014-2999(01)01255-9
Lodder, 2006, Diazepam to improve acute stroke outcome: results of the early GABA-ergic activation study in stroke trial. a randomized double-blind placebo-controlled trial, Cerebrovasc. Dis., 21, 120, 10.1159/000090210
Lyden, 2001, The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results, Neurology, 57, 1199, 10.1212/WNL.57.7.1199
Lyden, 2002, Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): final results, Stroke, 33, 122, 10.1161/hs0102.101478
MacKenzie, 1987, Cerebral circulatory and metabolic effects of perivascular neurotransmitters, CRC Crit. Rev. Clin. Neurobiol., 2, 357
MacManus, 1997, Gene expression induced by cerebral ischemia: an apoptotic perspective, J. Cereb. Blood Flow Metab., 17, 815, 10.1097/00004647-199708000-00001
Maiese, 1997, Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide, J. Neurochem., 68, 710, 10.1046/j.1471-4159.1997.68020710.x
Manley, 2004, New insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice, Neuroscience, 129, 983, 10.1016/j.neuroscience.2004.06.088
Marinov, 1996, Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia, J. Neurosurg., 85, 117, 10.3171/jns.1996.85.1.0117
Marshall, 1999, Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species, Exp. Neurol., 156, 121, 10.1006/exnr.1998.6994
Marshall, 2000, Clomethiazole protects against hemineglect in a primate model of stroke, Brain Res. Bull, 52, 21, 10.1016/S0361-9230(99)00275-0
Marshall, 2001, NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species, Stroke, 32, 190, 10.1161/01.STR.32.1.190
Marshall, 2003, Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion, Stroke, 34, 2228, 10.1161/01.STR.0000087790.79851.A8
Mattson, 1997, Neuroprotective signal transduction: relevance to stroke, Neurosci. Biobehav. Rev., 21, 193, 10.1016/S0149-7634(96)00010-3
Mayer, 2004, Clinical trial of a novel surface cooling system for fever control in neurocritical care patients, Crit. Care Med., 32, 2508, 10.1097/01.CCM.0000147441.39670.37
Mehta, 2007, Molecular targets in cerebral ischemia for developing novel therapeutics, Brain Res. Rev., 54, 34, 10.1016/j.brainresrev.2006.11.003
Meloni, 2006, Is magnesium neuroprotective following global and focal cerebral ischaemia? A review of published studies, Magnes Res., 19, 123
Mergenthaler, 2004, Pathophysiology of stroke: lessons from animal models, Metab. Brain Dis., 19, 151, 10.1023/B:MEBR.0000043966.46964.e6
Mies, 1993, Autoradiographic and biochemical imaging in cerebral ischemia, Adv. Exp. Med. Biol., 333, 273, 10.1007/978-1-4899-2468-1_25
Minematsu, 1993, Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-d-aspartate antagonist and reperfusion in experimental stroke in rats, Stroke, 24, 2074, 10.1161/01.STR.24.12.2074
Mir, 2003, CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons, J. Mol. Neurosci., 20, 53, 10.1385/JMN:20:1:53
Miyabe, 1997, Comparative analysis of brain protection by N-methyl-d-aspartate receptor antagonists after transient focal ischemia in cats, Crit. Care Med., 25, 1037, 10.1097/00003246-199706000-00022
Moher, 2001, Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation, J. Am. Med. Assoc., 285, 1992, 10.1001/jama.285.15.1992
Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials, J. Am. Med. Assoc., 285, 1987, 10.1001/jama.285.15.1987
Mohr, 1994, Meta-analysis of oral nimodipine trials in acute ischemic stroke, Cerebrovasc. Dis., 4, 197, 10.1159/000108482
Mokhtarani, 2001, Buspirone and meperidine synergistically reduce the shivering threshold, Anesth. Analg., 93, 1233, 10.1097/00000539-200111000-00038
Muir, 1994, Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers, Br. J. Clin. Pharmacol., 38, 33, 10.1111/j.1365-2125.1994.tb04318.x
Muir, 1995, Clinical pharmacology of CNS 1102 in volunteers, Ann. N.Y. Acad. Sci., 765, 279, 10.1111/j.1749-6632.1995.tb16585.x
Muir, 2004, Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial, Lancet, 363, 439, 10.1016/S0140-6736(04)15490-1
Muller, 1999, Piracetam: novelty in a unique mode of action, Pharmacopsychiatry, 32, 2, 10.1055/s-2007-979230
Mun-Bryce, 1998, Matrix metalloproteinases in cerebrovascular disease, J. Cereb. Blood Flow Metab., 18, 1163, 10.1097/00004647-199811000-00001
Nakajima, 2005, A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats, J. Pharmacol. Exp. Ther., 312, 472, 10.1124/jpet.104.075465
Namura, 2001, Ebselen reduces cytochrome c release from mitochondria and subsequent DNA fragmentation after transient focal cerebral ischemia in mice, Stroke, 32, 1906, 10.1161/01.STR.32.8.1906
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, Tissue plasminogen activator for acute ischemic stroke, N. Engl. J Med., 333, 1581, 10.1056/NEJM199512143332401
Nimmagadda, 2008, Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study, Stroke, 39, 198, 10.1161/STROKEAHA.107.495598
Noraberg, 2005, Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair, Curr. Drug Targets. CNS Neurol. Disord, 4, 435, 10.2174/1568007054546108
North American GAIN Investigators, 2000, Phase II studies of the glycine antagonist GV150526 in acute stroke: the North American experience. The North American Glycine Antagonist in Neuroprotection (GAIN) Investigators, Stroke, 31, 358, 10.1161/01.STR.31.2.358
O'Collins, 2006, 1,026 experimental treatments in acute stroke, Ann. Neurol., 59, 467, 10.1002/ana.20741
Olney, 1994, Neurotoxicity of NMDA receptor antagonists: an overview, Psychopharmacol. Bull., 30, 533
Ovbiagele, 2003, Neuroprotective agents for the treatment of acute ischemic stroke, Curr. Neurol. Neurosci. Rep., 3, 9, 10.1007/s11910-003-0031-z
Palesch, 2006, The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke. II. Neurological outcome and efficacy-analysis, Stroke, 37, 2107, 10.1161/01.STR.0000231389.34701.b5
Parnham, 2000, Ebselen: prospective therapy for cerebral ischaemia, Expert Opin. Invest. Drugs, 9, 607, 10.1517/13543784.9.3.607
Paschen, 2004, Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis, Curr. Neurovasc. Res., 1, 173, 10.2174/1567202043480125
Paschen, 1999, Disturbances of the functioning of endoplasmic reticulum: a key mechanism underlying neuronal cell injury?, J. Cereb. Blood Flow Metab., 19, 1, 10.1097/00004647-199901000-00001
Pedersen, 2006, Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl− cotransport in the heart, brain, and blood, Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R1, 10.1152/ajpregu.00782.2005
Pellegrini-Giampietro, 1997, The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders, Trends Neurosci., 20, 464, 10.1016/S0166-2236(97)01100-4
Perez-Pinzon, 2007, Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance, Comp. Biochem. Physiol. A Mol. Integr. Physiol., 147, 291, 10.1016/j.cbpa.2006.08.032
Perez-Pinzon, 2005, Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain, Antioxid. Redox. Signal, 7, 1150, 10.1089/ars.2005.7.1150
Phillis, 2003, The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries, Crit. Rev. Neurobiol., 15, 61, 10.1615/CritRevNeurobiol.v15.i1.30
Phillis, 2004, A potentially critical role of phospholipases in central nervous system ischemic, traumatic, and neurodegenerative disorders, Brain Res. Brain Res. Rev., 44, 13, 10.1016/j.brainresrev.2003.10.002
Phillis, 2006, Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders, Brain Res. Rev., 52, 201, 10.1016/j.brainresrev.2006.02.002
Piaggio, 2006, Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement, J. Am. Med. Assoc., 295, 1152, 10.1001/jama.295.10.1152
Planas, 2006, Signalling pathways mediating inflammatory responses in brain ischaemia, Biochem. Soc. Trans., 34, 1267, 10.1042/BST0341267
Polderman, 2006, Equipment review: cooling catheters to induce therapeutic hypothermia?, Crit. Care, 10, 234, 10.1186/cc5023
PubMed
Read, 2001, Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression, J. Cereb. Blood Flow Metab., 21, 755, 10.1097/00004647-200107000-00001
Reggiani, 2001, The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging, Eur. J. Pharmacol., 419, 147, 10.1016/S0014-2999(01)00948-7
Reinhart, 1995, Albumin affects erythrocyte aggregation and sedimentation, Eur. J. Clin. Invest., 25, 523, 10.1111/j.1365-2362.1995.tb01739.x
Reith, 1996, Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome, Lancet, 347, 422, 10.1016/S0140-6736(96)90008-2
Rodriguez de Turco, 2002, Systemic fatty acid responses to transient focal cerebral ischemia: influence of neuroprotectant therapy with human albumin, J. Neurochem., 83, 515, 10.1046/j.1471-4159.2002.01121.x
Rosenberg, 1999, Ischemic brain edema, Prog. Cardiovasc. Dis., 42, 209, 10.1016/S0033-0620(99)70003-4
Rothman, 1986, Glutamate and the pathophysiology of hypoxic-ischemic brain damage, Ann. Neurol., 19, 105, 10.1002/ana.410190202
Rutherford, 2005, Mild hypothermia and the distribution of cerebral lesions in neonates with hypoxic-ischemic encephalopathy, Pediatrics, 116, 1001, 10.1542/peds.2005-0328
Sacco, 2001, Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial, J. Am. Med. Assoc., 285, 1719, 10.1001/jama.285.13.1719
Salom, 2004, Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia, Eur. J. Pharmacol., 495, 55, 10.1016/j.ejphar.2004.05.024
SASS Trial, 1994, Ganglioside GM1 in acute ischemic stroke. The SASS Trial, Stroke, 25, 1141, 10.1161/01.STR.25.6.1141
Saver, 2007, Clinical impact of NXY-059 demonstrated in the SAINT I trial: derivation of number needed to treat for benefit over entire range of functional disability, Stroke, 38, 1515, 10.1161/01.STR.0000263135.47779.9e
Saver, 2004, Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial, Stroke, 35, e106, 10.1161/01.STR.0000124458.98123.52
Saver, 2006, Physician-investigator phone elicitation of consent in the field: a novel method to obtain explicit informed consent for prehospital clinical research, Prehosp. Emerg. Care, 10, 182, 10.1080/10903120500541035
Savitz, 2007, A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke, Exp. Neurol., 205, 20, 10.1016/j.expneurol.2007.03.003
Savitz, 2007, Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials, Ann. Neurol., 61, 396, 10.1002/ana.21127
Scandinavian Stroke Study Group, 1987, Multicenter trial of hemodilution in acute ischemic stroke. I. Results in the total patient population. Scandinavian Stroke Study Group, Stroke, 18, 691, 10.1161/01.STR.18.4.691
Scandinavian Stroke Study Group, 1988, Multicenter trial of hemodilution in acute ischemic stroke. Results of subgroup analyses. Scandinavian Stroke Study Group, Stroke, 19, 464, 10.1161/01.STR.19.4.464
Schabitz, 1996, The effects of prolonged treatment with citicoline in temporary experimental focal ischemia, J. Neurol. Sci., 138, 21, 10.1016/0022-510X(95)00341-X
Schabitz, 2000, The N-methyl-d-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats, Stroke, 31, 1709, 10.1161/01.STR.31.7.1709
Scheller, 1997, Lubeluzole blocks increases in extracellular glutamate and taurine in the peri-infarct zone in rats, Eur. J. Pharmacol., 338, 243, 10.1016/S0014-2999(97)81927-9
Schilling, 1999, Mediators of cerebral edema, Adv. Exp. Med. Biol., 474, 123, 10.1007/978-1-4615-4711-2_11
Schmidt-Kastner, 1991, Selective vulnerability of the hippocampus in brain ischemia, Neuroscience, 40, 599, 10.1016/0306-4522(91)90001-5
Schurr, 2004, Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels, Curr. Drug Targets, 5, 603, 10.2174/1389450043345209
Scriabine, 1989, Pharmacological basis for the use of nimodipine in central nervous system disorders, FASEB J., 3, 1799, 10.1096/fasebj.3.7.2565839
Secades, 1995, CDP-choline: pharmacological and clinical review. Methods Find, Exp. Clin. Pharmacol., 17, 1
Sena, 2007, Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke, Stroke, 38, 388, 10.1161/01.STR.0000254462.75851.22
Serebruany, 2006, Hypokalemia, cardiac failure, and reporting NXY-059 safety for acute stroke, J. Cardiovasc. Pharmacol. Ther., 11, 229, 10.1177/1074248406297311
Sharp, 2000, Multiple molecular penumbras after focal cerebral ischemia, J. Cereb. Blood Flow Metab., 20, 1011, 10.1097/00004647-200007000-00001
Sharp, 2002, Neurogenesis following brain ischemia, Brain Res. Dev. Brain Res., 134, 23, 10.1016/S0165-3806(01)00286-3
Shuaib, 2007, NXY-059 for the treatment of acute ischemic stroke, N. Engl. J. Med., 357, 562, 10.1056/NEJMoa070240
Siesjo, 1978
Siesjo, 1981, Cell damage in the brain: a speculative synthesis, J. Cereb. Blood Flow Metab., 1, 155, 10.1038/jcbfm.1981.18
Siesjo, 1992, Pathophysiology and treatment of focal cerebral ischemia. Part I: pathophysiology, J. Neurosurg., 77, 169, 10.3171/jns.1992.77.2.0169
Siesjo, 1989, Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis, J. Cereb. Blood Flow Metab., 9, 127, 10.1038/jcbfm.1989.20
Simard, 2007, Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications, Lancet Neurol., 6, 258, 10.1016/S1474-4422(07)70055-8
Simon, 1990, N-Methyl-d-aspartate antagonist reduces stroke size and regional glucose metabolism, Ann. Neurol., 27, 606, 10.1002/ana.410270604
STAIR, 1999, Recommendations for standards regarding preclinical neuroprotective and restorative drug development, Stroke, 30, 2752, 10.1161/01.STR.30.12.2752
Stenzel-Poore, 2007, Preconditioning reprograms the response to ischemic injury and primes the emergence of unique endogenous neuroprotective phenotypes: a speculative synthesis, Stroke, 38, 680, 10.1161/01.STR.0000251444.56487.4c
Stewart, 2006, Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced thrombolysis, J. Thromb. Haemost., 4, 1575, 10.1111/j.1538-7836.2006.01999.x
Strijbos, 1998, Nitric oxide in cerebral ischemic neurodegeneration and excitotoxicity, Crit. Rev. Neurobiol., 12, 223, 10.1615/CritRevNeurobiol.v12.i3.40
Stys, 1998, Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics, J Cereb. Blood Flow Metab., 18, 2, 10.1097/00004647-199801000-00002
Sugawara, 2003, Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia, Antioxid. Redox. Signal, 5, 597, 10.1089/152308603770310266
Sughrue, 2004, Effectively bridging the preclinical/clinical gap: the results of the ASTIN trial, Stroke, 35, e81, 10.1161/01.STR.0000121164.29117.44
Swanson, 2004, Astrocyte influences on ischemic neuronal death, Curr. Mol. Med., 4, 193, 10.2174/1566524043479185
Sydserff, 1995, The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat, Neurodegeneration, 4, 323, 10.1016/1055-8330(95)90022-5
Sydserff, 1995, The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia, Br. J. Pharmacol., 114, 1631, 10.1111/j.1476-5381.1995.tb14950.x
Sydserff, 2002, Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window, Br. J. Pharmacol., 135, 103, 10.1038/sj.bjp.0704449
Takahashi, 2002, YM872: a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, CNS Drug Rev., 8, 337, 10.1111/j.1527-3458.2002.tb00232.x
Takasago, 1997, Neuroprotective efficacy of ebselen, an anti-oxidant with anti-inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion, Br. J. Pharmacol., 122, 1251, 10.1038/sj.bjp.0701426
Tazaki, 1988, Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study, Stroke, 19, 211, 10.1161/01.STR.19.2.211
The RANTTAS Investigators, 1996, A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS). The RANTTAS Investigators, Stroke, 27, 1453, 10.1161/01.STR.27.9.1453
Tirilazad International Steering Committee, 2000, Tirilazad mesylate in acute ischemic stroke: a systematic review. Tirilazad International Steering Committee, Stroke, 31, 2257, 10.1161/01.STR.31.9.2257
Trendelenburg, 2005, Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning, Glia, 50, 307, 10.1002/glia.20204
TRUST Study Group, 1990, Randomised, double-blind, placebo-controlled trial of nimodipine in acute stroke. Trust Study Group, Lancet, 336, 1205, 10.1016/0140-6736(90)92829-7
Turner, 2007, New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection, Int. Rev. Neurobiol., 82, 113, 10.1016/S0074-7742(07)82006-X
Tymianski, 1996, Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury, Neurosurgery, 38, 1176
US National Institutes of Health
van der Worp, 2002, The effect of tirilazad mesylate on infarct volume of patients with acute ischemic stroke, Neurology, 58, 133, 10.1212/WNL.58.1.133
van der Worp, 2005, Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia, J. Neurol., 252, 1108, 10.1007/s00415-005-0802-3
Wahlgren, 1994, Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke, Cerebrovasc. Dis., 4, 204, 10.1159/000108483
Wahlgren, 1999, Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients, Stroke, 30, 21, 10.1161/01.STR.30.1.21
Wang, 2007, The inflammatory response in stroke, J. Neuroimmunol., 184, 53, 10.1016/j.jneuroim.2006.11.014
Wang, 2000, Influence of admission body temperature on stroke mortality, Stroke, 31, 404, 10.1161/01.STR.31.2.404
Warach, 2000, Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging, Citicoline 010 Investigators. Ann. Neurol., 48, 713, 10.1002/1531-8249(200011)48:5<713::AID-ANA4>3.0.CO;2-#
Warach, 2006, Effect of the glycine antagonist gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: the GAIN MRI substudy, Cerebrovasc. Dis., 21, 106, 10.1159/000090208
Warner, 2004, Oxidants, antioxidants and the ischemic brain, J Exp. Biol., 207, 3221, 10.1242/jeb.01022
Wass, 1996, Glucose modulation of ischemic brain injury: review and clinical recommendations, Mayo Clin. Proc., 71, 801, 10.4065/71.8.801
Watanabe, 1994, Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions, J. Pharmacol. Exp. Ther., 268, 1597
Waxman, 1991, Non-synaptic mechanisms of Ca(2+)-mediated injury in CNS white matter, Trends Neurosci., 14, 461, 10.1016/0166-2236(91)90046-W
Wayner, 1985, Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins, FEBS Lett., 187, 33, 10.1016/0014-5793(85)81208-4
Weiss, 1995, Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline, Life Sci., 56, 637, 10.1016/0024-3205(94)00427-T
Westermaier, 2005, Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats, Acta Neurochir. (Wien), 147, 525, 10.1007/s00701-005-0496-4
Wieloch, 1985, Neurochemical correlates to selective neuronal vulnerability, Prog. Brain Res., 63, 69, 10.1016/S0079-6123(08)61976-7
Wieloch, 1993, Protein phosphorylation and the regulation of mRNA translation following cerebral ischemia, Prog. Brain Res., 96, 179, 10.1016/S0079-6123(08)63266-5
Wilby, 2004, The pharmacology of chlormethiazole: a potential neuroprotective agent?, CNS Drug Rev., 10, 281, 10.1111/j.1527-3458.2004.tb00028.x
Winblad, 2005, Piracetam: a review of pharmacological properties and clinical uses, CNS Drug Rev., 11, 169, 10.1111/j.1527-3458.2005.tb00268.x
Witlin, 1998, Magnesium sulfate therapy in preeclampsia and eclampsia, Obstet. Gynecol., 92, 883, 10.1016/S0029-7844(98)00277-4
Wu, 2005, Neuroprotection in experimental stroke with targeted neurotrophins, NeuroRx, 2, 120, 10.1602/neurorx.2.1.120
Xiong, 2007, Acid sensing ion channels – novel therapeutic targets for ischemic brain injury, Front Biosci., 12, 1376, 10.2741/2154
Xue, 1994, Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction, J. Cereb. Blood Flow Metab., 14, 251, 10.1038/jcbfm.1994.32
Yamaguchi, 1998, Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group, Stroke, 29, 12, 10.1161/01.STR.29.1.12
Yang, 2000, Survival and histological evaluation of therapeutic window of post-ischemia treatment with magnesium sulfate in embolic stroke model of rat, Neurosci. Lett., 285, 119, 10.1016/S0304-3940(00)01048-X
Yon, 2004, A novel system for mild hypothermia, Biomed. Instrum. Technol., 38, 241
Young, 2004, Excitotoxic versus apoptotic mechanisms of neuronal cell death in perinatal hypoxia/ischemia, Curr. Mol. Med., 4, 77, 10.2174/1566524043479158
Yrjanheikki, 1998, Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia, Proc. Natl. Acad. Sci. U.S.A., 95, 15769, 10.1073/pnas.95.26.15769
Zhang, 2004, Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms, Neurol. Res., 26, 835, 10.1179/016164104X3824
Zhang, 2005, Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain, Stroke, 36, 2220, 10.1161/01.STR.0000182241.07096.06
Zhang, 1995, Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat, Stroke, 26, 1438, 10.1161/01.STR.26.8.1438
Zhang, 2005, Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy, Neuroscientist, 11, 408, 10.1177/1073858405278865
Zhao, 2006, Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke, Mol. Neurobiol., 34, 249, 10.1385/MN:34:3:249
Zhao, 1997, Transient middle cerebral artery occlusion by intraluminal suture: II. Neurological deficits, and pixel-based correlation of histopathology with local blood flow and glucose utilization, J. Cereb. Blood Flow Metab., 17, 1281, 10.1097/00004647-199712000-00003
Zhao, 2001, NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat, Brain Res., 909, 46, 10.1016/S0006-8993(01)02618-X